Shanghai RAAS Blood Products Investor Relations Material
Latest events
Q2 2025
30 Aug, 2025
Q1 2025
28 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shanghai RAAS Blood Products Co Ltd
Access all reports
Shanghai RAAS Blood Products Co., Ltd. is a Chinese healthcare company focused on the research, development, production, and distribution of plasma-derived biopharmaceutical products. The company produces a variety of blood plasma-based therapies, including immunoglobulins, albumin, and coagulation factor products, used in the treatment of immune deficiencies, blood disorders, and other medical conditions. The company is headquartered in Shanghai, China, and its shares are listed on the Shenzhen Stock Exchange.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
002252
Country
🇨🇳 China